SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation -- Ignore unavailable to you. Want to Upgrade?

To: WalleyB who wrote (23)12/16/1997 10:56:00 AM
From: Steven W.Read Replies (1) | Respond to of 557
 
Jim,

I bought a 100 shares of TGEN today. I usually don't buy stocks on
the way down, but looking at the last few Decembers, it has had a
nice bounce in January.

At $2 11-16, I am not to worried about it. Biotechs can give you a
major roller coaster effect. The key is to sell on the way up and not
look back.

Steve



To: WalleyB who wrote (23)7/12/1998 1:09:00 AM
From: alan f. wilsonRead Replies (1) | Respond to of 557
 
all follower of tgen you are missing the key connection..closely associated with the fred hutchinson cancer insitute in seattle.. they are leading edge biotech. when this one goes it will be the genetic cancer cure delivery system the world has waited for ........


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News